Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News:
----------
Yourgene Health PLC - Manchester-based molecular diagnostics - Chief Executive Officer Lyn Rees buys 1.0 million shares at 7.1 pence each, worth £71,000, on Wednesday. Now has 2.0 million shares, a 0.3% stake.
----------
Big Technologies PLC - UK-based remote people monitoring technology - Chief Financial Officer Daren Morris buys 30,000 shares at average £2.43, worth £72,900, on Tuesday. Now has 360,000 shares, a 0.1% stake.
----------
GlaxoSmithKline PLC - Brentford, Middlesex-based pharmaceuticals and consumer healthcare products - Hal Barron, chief scientific officer & president of research & development, buys 1,193 notional American Depositary Shares, each worth two ordinary shares, at $43.16, worth $51,490, on Monday.
----------
Manchester & London Investment Trust PLC - technology-focused growth-stock investor - Mark Sheppard transfers 37,721 shares, worth £140,322, to Richard Morgan, on Wednesday. Both are investment managers of the trust.
----------
Copyright 2022 Alliance News Limited. All Rights Reserved.